Siemens Health sets investor-friendly range on IPO
Siemens has chosen to set a price range designed to please investors on the IPO of its medical technology division Siemens Healthineers, rather than seeking an aggressive valuation.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: